- Chemical Name:Cellulose, Microcrystalline
- CAS Number:9004-34-6
- Dosage Form:Tablets
- Labeling Claims:Dioxin-free, BSE-free, Phthalates-free, Kosher, Colorants-free, Endocrine Disruptor-free, Allergen-free, PHO (Partially Hydrogenated Oil)-Free, Dye Free, TSE-free, Antibiotics-free, Palm Oil-free, Sugar-free, PVC-free, Aluminum-free, Pesticide-free, Paraben-free, Halal, Triphenyl Tin Compounds-Free, Plasticizer-free, Monosodium Glutamate (MSG)-free, Generally Recognized As Safe (GRAS), Caffeine Free, Preservative-free, Glycerin-free, Vegetarian, Bisphenol A-free, Ethylene Oxide-free, Latex-free, APE-free, Hormones-free, GMO-free, Natural Latex Rubber-Free, Nitrosamines-free, Perfluorooctanoic Acid-free, PFOS-free, Non-GMO, Heavy Metal-free, PFAS-Free, PAH-free, Tributyl Tin Compounds-Free
- Certifications & Compliance:cGMP, Halal, British Pharmacopeia (BP), FDA Food Safety Modernization Act (FSMA), Regulation (EU) No. 1272/2008, Kosher, EXCiPACT, Doping-Free, United States Pharmacopeia (USP), European Regulation 396/2005/EC, European Pharmacopeia (Ph. Eur.), EU Cosmetic Regulation 1223/2009 Compliant, IFRA Compliant, FDA Compliant, Regulation (EU) No. 231/2012, ICH Q3C, National Formulary (NF), Japan Pharmacopeia (JP), Generally Recognized As Safe (GRAS)
- Manufacturing Technology:Dry Granulation, Wet Granulation, Direct Compression
Avicel® PH - 113 composed of microcrystalline cellulose, finds application in tablet formulations. Manufactured using direct compression, dry granulation, and wet granulation techniques, it serves as a binder and compression aid. Derived from non-animal sources, it meets pharmaceutical and nutraceutical standards.
